Skip to content
Neuro-ophthalmology

Rathke's Cleft Cyst

Rathke’s cleft cyst (RCC) is a benign cystic lesion that arises when Rathke’s pouch does not completely regress during pituitary formation, and mucus accumulates in the remnant Rathke’s cleft, causing enlargement. It originates from the degenerated intermediate part (pars intermedia) between the adenohypophysis (anterior lobe) and neurohypophysis (posterior lobe).

Epidemiologically, autopsy studies report an incidence of 12–33% 1), and most are asymptomatic and discovered incidentally. Among pituitary tumors requiring surgical management, RCC accounts for only 2–9%. The peak age of onset is 30–50 years, with a female predominance (male-to-female ratio 1:1 to 1:5). Pediatric cases are rare but have been reported 5).

Both RCC and craniopharyngioma originate from the same Rathke’s cleft. The difference lies in the contents: RCC contains only fluid, whereas craniopharyngioma also contains solid components.

Q How are Rathke's cleft cyst and craniopharyngioma different?
A

Both arise from the Rathke’s cleft. RCC is a benign cystic lesion containing only fluid, whereas craniopharyngioma is a neoplastic lesion with solid components and calcification. Craniopharyngioma is often more invasive and difficult to treat.

Approximately 60% of RCCs are asymptomatic. Symptomatic cases present with the following symptoms.

  • Headache: One of the most common symptoms. In 61 cases reported by Tang (2022), it was observed in 88.5%, and 72.2% had paroxysmal frontal headache 1). This is thought to be partly due to intermittent inflammatory reactions caused by cyst contents.
  • Visual disturbances: Including decreased visual acuity, visual field narrowing, and diplopia, more common in cases with suprasellar extension. Observed in 49.2% (30 cases) of 61 cases 1).
  • Symptoms associated with endocrine dysfunction: Amenorrhea, decreased libido, fatigue, polydipsia and polyuria (diabetes insipidus), etc.
  • Onset pattern: Mostly gradual and insidious. Rarely, acute onset due to intracystic hemorrhage (RCC apoplexy) may occur.

Clinical Findings (Findings Confirmed by Physician Examination)

Section titled “Clinical Findings (Findings Confirmed by Physician Examination)”
  • Bitemporal hemianopia: The most typical visual field defect. Caused by compression of the optic chiasm by the cyst. Often more prominent inferiorly (see mechanism below).
  • Specific mechanism of visual field defect: Because RCC is a flexible cyst, rather than directly compressing the optic chiasm, the cyst displaces the chiasm upward, and the floor of the third ventricle compresses the superior aspect of the chiasm. As a result, the superonasal crossing fibers are preferentially damaged, often leading to inferior bitemporal hemianopia.
  • Band atrophy: An optic disc finding specific to chiasmal lesions. Thinning of the papillomacular bundle and nasal radial fibers leads to selective atrophy of the horizontal quadrant.
  • Optical coherence tomography (OCT) findings: Selective thinning of the nasal macular inner retinal layers, thinning of the temporal and nasal quadrants of the cpRNFL. Useful for assessing the degree of chiasmal compression and estimating prognosis after treatment.
  • Endocrine dysfunction: Hyperprolactinemia (16%) and diabetes insipidus (21%) are common, and growth hormone deficiency is also frequent. Panhypopituitarism has been reported even in pediatric cases 5).
Q Why does bitemporal hemianopia in Rathke's cleft cyst tend to be inferiorly dominant?
A

Because RCC is a flexible cyst, rather than directly compressing the optic chiasm, the cyst displaces the chiasm upward, and the floor of the third ventricle compresses the chiasm from above. The superonasal crossing fibers are damaged, resulting in inferiorly dominant bitemporal hemianopia.

RCC is caused by incomplete regression/closure of the Rathke’s pouch (which arises from the oral ectoderm at 3–4 weeks of gestation). Mucus accumulates and enlarges in the residual cleft, forming an RCC.

Most are located in or near the midline within the sella turcica to the suprasellar region, but rarely they may extend into the sphenoid sinus, cavernous sinus, or frontal region.

Risk factors associated with recurrence are as follows3).

  • Large cyst size: Larger cysts have a higher risk of recurrence.
  • Contrast enhancement on MRI: Ring enhancement is associated with recurrence.
  • Suprasellar location: Lesions in the suprasellar region are more likely to recur than intrasellar ones.
  • Squamous metaplasia: Inflammation of the cyst wall promotes squamous metaplasia, leading to re-accumulation of cyst fluid.

Cyst size and symptom severity do not always correlate. Chronic inflammation of the cyst wall may cause symptoms independently of simple compression4).

MRI is the central imaging test for diagnosing RCC.

  • Basic findings: Depicted as a well-defined oval to dumbbell-shaped cystic mass.
  • Signal intensity: Varies depending on the nature of the cyst contents. CSF-like contents show T1 low signal/T2 high signal, while mucinous contents show T1 high signal/T2 low signal. The most common is T2 high signal (about 70%).
  • Intracystic nodule: A nodule that is T2 low signal/T1 high signal and not enhanced is a specific finding strongly suggestive of RCC2).
  • Contrast enhancement: RCC itself does not enhance. Ring-like marginal enhancement is due to enhancement of the compressed pituitary gland and is seen in about half of cases.
  • T1 hyperintense RCC: It has been reported to be highly associated with headache and pituitary dysfunction4).

MRI alone may be insufficient to differentiate from cystic pituitary adenoma. The following classification methods are useful for diagnostic assistance2).

  • Tavakol classification: A 4-type classification based on morphology. No solid component, well-defined, homogeneous cyst (Type 1) is most likely a non-neoplastic lesion (RCC). Types 3-4 are more likely pituitary adenoma.
  • Park’s diagnostic decision tree: Three conditions (midline location, no fluid-fluid level, presence of intracystic nodule) achieve 91.6% diagnostic accuracy for RCC.
DiseaseDistinguishing Features
Cystic pituitary adenomaFluid-fluid level, hemorrhagic debris, septations, eccentric location
CraniopharyngiomaSolid component, calcification
Arachnoid cystCommon in suprasellar cistern; sometimes difficult to differentiate
Lymphocytic hypophysitisPituitary gland appears as a triangle with convex superior margin
  • Visual field test: Evaluate bitemporal hemianopia using Humphrey automated perimetry.
  • Endocrine tests: Anterior pituitary hormones (GH, PRL, ACTH, TSH, LH/FSH) and AVP (for diabetes insipidus assessment).
  • OCT: Objective assessment of band atrophy. Useful for evaluating the degree of optic chiasm compression and estimating prognosis after treatment.
  • Histopathological confirmation: Final diagnosis is made by biopsy. Characteristic findings include single to multiple layers of cuboidal/columnar epithelium, cilia, mucus-secreting goblet cells, and squamous metaplasia.

Small asymptomatic cysts do not require surgery. Follow-up with regular imaging, endocrine tests, and visual field tests. Long-term follow-up studies of asymptomatic RCC show that most remain unchanged or shrink, with enlargement exceeding 3 mm occurring in only 5.1% of cases 5).

For symptomatic RCC, endoscopic endonasal transsphenoidal approach (EETA) is currently the standard surgical technique 1). The surgical strategy involves a combination of cyst decompression, total removal of cyst contents, partial resection of the cyst wall, and non-filling of the cyst cavity.

Radical Resection

Recurrence rate: 9–18.2%

Complication rate: Up to 47%, which is high

Complete resection of the cyst wall. The reduction in recurrence rate is limited compared to the increase in complication rate.

Partial Resection

Recurrence rate: 11–21.2%

Complication rate: Lower than radical resection

Partial resection of the cyst wall. No significant difference in recurrence rate compared to radical resection. Current standard approach.

Alcohol ablation does not reduce recurrence and increases complication risk, so it is no longer recommended 1). If visual field defects progress, prompt neurosurgical removal is necessary.

Postoperative outcomes (Tang 2022 — 61 cases) 1)

Section titled “Postoperative outcomes (Tang 2022 — 61 cases) 1)”
  • Headache improvement: All cases (100%)
  • Visual impairment improvement: 22/30 cases (73.3%)
  • Pituitary function improvement: All cases (100%)
ComplicationFrequencyCourse
Transient diabetes insipidus23% (14 cases)Resolves spontaneously in about 10 days
Transient hypopituitarism11.5% (7 cases)Improves in about 3 weeks
Permanent diabetes insipidusUp to 20%Persistent
Cerebrospinal fluid leakUp to 25%May require reoperation

When endocrine dysfunction is predominant and visual impairment is mild, hormone replacement therapy and observation are options3)5). In inflammatory RCC, steroid therapy has been shown to potentially contribute to cyst shrinkage4), and conservative management is considered in elderly patients at high surgical risk3).

Q Is complete surgical removal of the cyst wall less likely to cause recurrence?
A

There is no significant difference in recurrence rates between radical resection and partial resection (radical resection 9–18.2%, partial resection 11–21.2%). However, radical resection has a complication rate as high as 47%, so partial resection is now the standard approach1).

6. Pathophysiology and Detailed Mechanisms

Section titled “6. Pathophysiology and Detailed Mechanisms”

Rathke’s cleft develops from the oral ectoderm at 3–4 weeks of gestation and joins with the neuroectoderm of the diencephalon to form the anterior lobe (adenohypophysis) and posterior lobe (neurohypophysis). The remnant of the intermediate part (pars intermedia) between these structures, known as Rathke’s cleft, persists, and RCCs and craniopharyngiomas arise from this site. Accumulation of mucus secreted by the epithelial cells of the cyst wall leads to cyst enlargement.

Inflammation of the cyst wall plays an important role in symptom formation. Cyst size and symptom severity do not always correlate; the inflammatory response to mucoid contents may be the main cause of headache and pituitary dysfunction4). When the cyst ruptures, xanthogranulomatous inflammation occurs2).

Because RCCs are flexible, they do not directly compress the optic chiasm. Instead, the cyst displaces structures upward, causing the floor of the third ventricle to compress the upper part of the optic chiasm, leading to damage of the superonasal nerve fibers. This results in inferior bitemporal hemianopsia.

The mechanism of spontaneous regression is not clearly understood, but hypotheses include imbalance between CSF secretion and reabsorption, cyst rupture with reabsorption of contents, and anti-inflammatory effects of steroid therapy3).


7. Latest Research and Future Perspectives (Investigational Reports)

Section titled “7. Latest Research and Future Perspectives (Investigational Reports)”

Nonabsorbable intrasellar stent placement for recurrent RCC

Section titled “Nonabsorbable intrasellar stent placement for recurrent RCC”

Ellens et al. (2021) reported a case of multiply recurrent RCC in which a nonabsorbable intrasellar stent using a tympanostomy tube was placed to maintain patency of the dural opening and allow continuous drainage of cyst fluid 6). No clinical or imaging recurrence was observed at 1 year postoperatively.

Conventional bioabsorbable steroid-eluting stents dissolve within 3 months, which may be insufficient to prevent late recurrence. Nonabsorbable stents may offer a long-term solution but carry risks of infection, inflammation, and migration 6).

New classification for preoperative imaging diagnosis

Section titled “New classification for preoperative imaging diagnosis”

Cuellar-Hernández et al. (2024) reported that combining the Tavakol classification with Park’s diagnostic decision tree improves preoperative differentiation between cystic pituitary adenoma and RCC 2). Radiomics and deep learning-based differentiation are also under development, but prospective studies and multicenter external validation have not yet been performed.

Conservative management of inflammatory RCC

Section titled “Conservative management of inflammatory RCC”

Hasebe et al. (2025) reported a case of RCC in a 68-year-old woman with recurrent inflammatory activity accompanied by short-term fluctuations in cyst size, in which conservative management with desmopressin alone led to resolution of headache and marked cyst shrinkage 4). Surgery is considered unlikely to improve AVP-D, and conservative management may be a valid option for inflammatory RCC.

Bano et al. (2025) reported a case of panhypopituitarism due to RCC in a 16-year-old boy managed solely with hormone replacement therapy, resulting in a 6 cm height increase and mild cyst shrinkage over 12 months 5). In a comparative analysis of 24 pediatric cases, cyst regression was observed in 35% of the conservatively managed group.

Q Can a Rathke's cleft cyst resolve without surgery?
A

In the literature, 21 cases of spontaneous regression have been reported. In inflammatory RCC, cyst shrinkage has been achieved with conservative management (steroid therapy and hormone replacement therapy) alone 3)4). However, the course varies by individual case, so regular imaging and visual field follow-up are essential.


  1. Tang C, Wang P, Liu J, et al. Endoscopic endonasal transsphenoidal approach for symptomatic Rathke cleft cyst: A case series. Exp Ther Med. 2022;24:713.
  2. Cuellar-Hernández JJ, Ortega-Ruiz OR, Rodriguez-Armendariz AG, et al. Accurate preoperative diagnosis of a Rathke cleft cyst with the aid of a novel classification for sellar cystic lesions and a diagnostic algorithm decision. Surg Neurol Int. 2024;15:120.
  3. Chaudhry M, Botterbush K, Zhang JK, et al. Spontaneous and asymptomatic rupture of an RCC with resolution of symptoms. BMJ Case Rep. 2024;17:e258534.
  4. Hasebe M, Tsukaguchi R, Shibue K, et al. Conservative management of symptomatic Rathke cleft cyst with recurrent inflammatory remission. JCEM Case Rep. 2025;3:luaf008.
  5. Bano T, Alghamdi NN, Altwijri AJ. Rathke cleft cyst presenting as panhypopituitarism in an adolescent. JCEM Case Rep. 2025;3:luaf129.
  6. Ellens NR, Miller MC, Shafiq I, et al. Nonabsorbable intrasellar stent placement for recurrent Rathke cleft cyst: illustrative case. J Neurosurg Case Lessons. 2021;1(15):CASE2117.

Copy the article text and paste it into your preferred AI assistant.